Pharmagenesis, Inc.
Records under this name other than patents Pharmagenesis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,863,464 | Triptolide lactone ring derivatives as immunomodulators and anticancer agents Lapsed on the fee record Ended Jan 4, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 4, 2023 | From the USPTO record |
| US 8,426,616 | Triptolide lactone ring derivatives as immunomodulators and anticancer agents Lapsed on the fee record Ended Apr 23, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2021 | From the USPTO record |
| US 8,268,882 | Triptolide C-ring derivatives as anticancer agents and immune modulators Lapsed on the fee record Ended Sep 18, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2020 | From the USPTO record |
| US 7,662,976 | Triptolide derivatives for modulation of apoptosis and immunosuppression Lapsed on the fee record Ended Feb 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2018 | From the USPTO record |
| US 6,991,817 | Acid-modified arabinogalactan protein composition Lapsed on the fee record Ended Jan 31, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jan 31, 2018 | From the USPTO record |
| US 8,617,906 | Identification and screening of triptolide target molecules Lapsed on the fee record Ended Dec 31, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 31, 2017 | From the USPTO record |
| US 6,943,259 | Halogenated triptolide derivatives as immunomodulators and anticancer agents Lapsed on the fee record Ended Sep 13, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2017 | From the USPTO record |
| US 7,417,069 | Halogenated triptolide derivatives as immunomodulators and anticancer agents Lapsed on the fee record Ended Aug 26, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 26, 2016 | From the USPTO record |
| US 8,048,914 | Methods for isolation of triptolide compounds from Tripterygium wilfordii Lapsed on the fee record Ended Nov 1, 2015 · From the USPTO record | Lapsed on the fee record | Ended Nov 1, 2015 | From the USPTO record |
| US 6,620,843 | Anticancer treatment using triptolide prodrugs Lapsed on the fee record Ended Sep 16, 2015 · From the USPTO record | Lapsed on the fee record | Ended Sep 16, 2015 | From the USPTO record |